The Lung Cancer Policy Network aims to build momentum for policy action around lung cancer screening. As part of this, we will soon launch an interactive map collating research on the implementation of low-dose computed tomography (LDCT) screening from around the world.
The map is being developed in close consultation with our Network members, who are world-renowned experts in lung cancer and lung cancer screening.
A global snapshot of screening implementation
The aim of the interactive map is to facilitate the sharing of best practice and to guide policy development around using LDCT screening to detect lung cancer. It is designed to be a comprehensive resource that collates ongoing and completed implementation research for LCDT screening globally.
In addition to the map, an interactive data dashboard will enable the direct comparison of different approaches to screening adopted at the local, national or global level. The dashboard will showcase examples of current organised lung cancer screening and the status of early detection of lung cancer.
A tool that facilitates policy discussions
The map can be used by policymakers, researchers and lung cancer advocates to support policy discussions around the status of and evidence for detecting lung cancer earlier. It can also facilitate data sharing between different stakeholders – case studies from the map can inform and promote the implementation of LDCT screening in new locations.
The first edition of the interactive map will be launched on our website in September.
Lung cancer screening in Japan
Since 1987, Japan has offered chest X-ray screening to people aged 40 or older. However, LDCT screening in Japan is commonly performed on a voluntary basis.
Meet our members: Witold Rzyman
We speak to Witold Rzyman, Chief Surgeon at the Department of Thoracic Surgery, Medical University of Gdańsk, Poland.
The Lung Cancer Policy Network’s statement on the EU Recommendation on cancer screening
The Lung Cancer Policy Network welcomes the inclusion of lung cancer in the EU Council Recommendation and now looks towards the implementation of effective lung cancer screening programmes.